Fig. 3From: Combination therapy with immune checkpoint inhibitors (ICIs); a new frontierThe pivotal role of vascular endothelium growth factor (VEGF) in tumor angiogenesis. The VEGF encourages angiogenesis in tumor cells by interface with responding receptor, VEGFR2, on tumor cells and afterward through activating several signaling axesBack to article page